Previsão

O preço-alvo médio dos analistas é € 39,06 (+2,47%). A mediana é € 41,01 (+7,58%).

Comprar
  8
Manter
  0
Vender
  0

Discussões na comunidade

Ainda não há nenhuma discussão sobre este ativo.

Iniciar discussão

  • Concentra Group Holdings Parent Inc reaches all-time high of $35.94

    Shares of Concentra Group Holdings Parent Inc climbed to a record high of $35.94, putting the stock close to its 52-week high; market capitalization is $4.46 billion. Year-to-date the share price is up about 79% and it has risen 67.78% over the past year. For Q2 Concentra reported revenue of $606 million and adjusted earnings per share of $0.52, raised its full-year guidance and cited improved margins and stronger cash flow. S&P Global Ratings upgraded the rating from BB- to BB and also raised certain bond and loan ratings, while adjusted leverage fell to 3.3x with targets of 3x and 2.5x net. » Mais em de.investing.com


  • Concentra announces leadership change and emphasizes strong growth and margin expansion

    Concentra unveils a planned management change effective November 1, with Matthew DiCanio named president and CEO, Tanner Newton as CFO and Keith Newton as executive chairman. The company reports robust operating momentum with above-target patient growth, nine consecutive quarters of meeting or exceeding goals since the IPO, margin expansion and a net leverage ratio of 2.99 at the end of Q2. Growth drivers include onsite services (revenue > $150 million, organic growth > 20%), accelerated new openings and targeted acquisitions; the separation from Select Medical is nearly complete and provides financial flexibility for M&A and share buybacks. » Mais em de.investing.com


  • S&P raises Concentra rating to BB as debt falls

    S&P Global Ratings has raised Concentra’s long-term rating from BB- to BB, and also upgraded the rating on senior secured loans to BB+ and on unsecured bonds to B+. The upgrade was driven by strong operating results, adjusted leverage below 3.5x in the second quarter, and expected improvements to about 3.3x in 2026 and 3.0x in 2027; management’s net-leverage target is 2.5x. S&P praises higher adjusted EBITDA, strong operating cash flows and Concentra’s market-leading position in occupational health, but assigns a stable outlook and warns that persistently high leverage from aggressive M&A or distributions would pose a downgrade risk. » Mais em de.investing.com


  • Concentra opens first medical center in Boise and plans second location in Idaho

    Concentra has opened its first medical center in Boise, offering work-injury treatment, physical therapy, drug testing, DOT exams, pre-employment screenings and occupational health services. The facility complements telemedicine services via Concentra Telemed; a second location in Meridian is expected later this year. As of March 31, 2026, Concentra operated 632 occupational health centers and 411 onsite clinics, reported revenue growth of 15.46%, revenue of $2.23 billion and a market capitalization of $4 billion. » Mais em de.investing.com


  • Concentra exceeds revenue and earnings expectations in Q1 2026

    Concentra reported revenue of $569.6 million for the first quarter of 2026 (up 13.7% year‑over‑year) and earnings per share of $0.40 (up 21%). The On‑Site Health Clinics segment grew 125%, adjusted EBITDA was $120.7 million, and free cash flow jumped to $9.9 million. The stock rose 4.53% in after‑hours trading; the company reaffirmed an optimistic outlook with projected EPS of $1.44 for 2026 and plans to expand with new de novo centers. » Mais em de.investing.com

Em 2026, Concentra Group já distribuiu € 0,16 em dividendos. A última distribuição ocorreu em agosto.

Dados financeiros

No último trimestre, Concentra Group registou receitas de € 549,24 mi e um ganho líquido de € 58,17 mi

(EUR) setembro de 2026
YoY
Receitas 549,24 mi 12,53%
Ganho bruto 172,57 mi 21,08%
Ganho líquido 58,17 mi 41,45%
EBITDA 119,49 mi 20,28%

Dados fundamentais

Métrica Valor
Capitalização bolsista
€ 4,82 bi
Número de ações
126,52 mi
Máximo/mínimo de 52 semanas
€ 40,30 - € 17,36
Rentabilidade de dividendos
0,56%
Dividendos TTM
€ 0,22
Próximo dividendo
€ 0,057
Beta
0,63
PER (PE Ratio)
24,76
PEG (PEG Ratio)
0,62
P/VC (PB Ratio)
10,49
P/V (PS Ratio)
2,27

Perfil da empresa

A Concentra Group Holdings Parent, Inc. presta serviços de saúde ocupacional nos Estados Unidos. A empresa oferece serviços de saúde ocupacional e de consumo, incluindo cuidados para lesões no âmbito de indemnizações por acidentes de trabalho, cuidados de urgência, testes clínicos, cuidados preventivos e serviços para empregadores, bem como programas de bem-estar através de centros de saúde ocupacional e clínicas no local de trabalho. A empresa disponibiliza também a Concentra Telemed, uma solução de telemedicina para o tratamento de lesões e doenças relacionadas com o trabalho, e serviços para empregadores; uma solução farmacêutica sob a denominação Concentra Pharmacy; e a Concentra Medical Compliance Administration, uma entidade gestora terceirizada que ajuda a gerir programas de testes de consumo de substâncias para empregadores com efetivos sujeitos ou não sujeitos a regulamentação. A empresa foi fundada em 1979 e tem sede em Mechanicsburg, Pensilvânia. A Concentra Group Holdings Parent, Inc. opera como subsidiária da Select Medical Corporation.

Nome
Concentra Group
CEO
Matthew T. DiCanio
Sede Addison, tx
EUA
Site
Indústria
Cuidados de saúde: prestadores e serviços
Entrada em bolsa
25/05/2010
Colaboradores 9.983

Símbolos de ticker

Bolsa Símbolo
NYSE
CON
🍪

Parqet  utiliza cookies. Saber mais